CircSPIDR acts as a tumour suppressor in cervical adenocarcinoma by sponging miR-431-5p and regulating SORCS1 and CUBN expression.
CircSPIDR acts as a tumour suppressor in cervical adenocarcinoma by sponging miR-431-5p and regulating SORCS1 and CUBN expression.
复制标题
CircSPIDR通过海绵状转移miR-431- 5 p并调节SORCS 1和CUBN表达在宫颈腺癌中起肿瘤抑制作用。
DOI:
10.18632/aging.203283
复制
发表时间:
2021-07-29
期刊:
影响因子:
--
通讯作者:
Lu W
中科院分区:
文献类型:
--
作者:
Xu J;Lu W
To identify circular RNAs (circRNAs) with tumor suppressor activity against cervical adenocarcinoma, we compared the circRNA levels of cervical adenocarcinoma and normal cervical tissues. We found that circSPIDR was dramatically downregulated in cervical adenocarcinoma tissues. In cervical adenocarcinoma cells, overexpression of circSPIDR reduced cell viability, inhibited colony formation and promoted apoptosis, whereas knockdown of circSPIDR exerted the opposite effects. CircSPIDR overexpression also suppressed the tumorigenicity of cervical adenocarcinoma cells in a xenograft mouse model. CircSPIDR was found to sponge miR-431-5p, thereby de-repressing sortin-related VPS10 domain-containing receptor 1 (SORCS1) and cubilin (CUBN) and inhibiting the development of cervical adenocarcinoma. In clinical cervical samples, circSPIDR expression correlated negatively with miR-431-5p expression and positively with SORCS1 and CUBN expression. These results demonstrated that circSPIDR suppresses cervical adenocarcinoma by competitively binding to miR-431-5p, thus upregulating SORCS1 and CUBN. These findings suggest circSPIDR could serve as a novel therapeutic target for treatment of cervical adenocarcinoma patients.
登录
查看更多内容
影响因子:
16.6
作者:
Gao Y;Wang J;Zheng Y;Zhang J;Chen S;Zhao F
通讯作者:
Zhao F
影响因子:
3.8
作者:
Gremel G;Djureinovic D;Niinivirta M;Laird A;Ljungqvist O;Johannesson H;Bergman J;Edqvist PH;Navani S;Khan N;Patil T;Sivertsson Å;Uhlén M;Harrison DJ;Ullenhag GJ;Stewart GD;Pontén F
通讯作者:
Pontén F
影响因子:
7.7
作者:
Paterson AD;Waggott D;Boright AP;Hosseini SM;Shen E;Sylvestre MP;Wong I;Bharaj B;Cleary PA;Lachin JM;MAGIC (Meta-Analyses of Glucose and Insulin-related traits Consortium);Below JE;Nicolae D;Cox NJ;Canty AJ;Sun L;Bull SB;Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
通讯作者:
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
DOI:
10.1006/bbrc.1999.1822
发表时间:
1999-12-20
影响因子:
3.1
作者:
Hermey, G;Riedel, IB;Hermans-Borgmeyer, I
通讯作者:
Hermans-Borgmeyer, I
影响因子:
30.8
作者:
Aminoff, M;Carter, JE;Krahe, R
通讯作者:
Krahe, R